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  Lyme disease has emerged as an increasing problem for people in the east and 
northeastern part of the United States.  It can cause a chronic debilitating infection if left 
untreated and is difficult to diagnose.  The illness is caused by an infection with the spirochete 
known as Borrelia burgdorferi.  B. burgdorferi is a Gram-negative bacterium that is transmitted 
by ticks of the Ixodes genus.  The primary carriers in regions of high Lyme disease incidence are 
Ixodes scapularis vector and white-footed Mus musculus rodents.   B. burgdorferi is not known 
to produce common virulence factors such as toxins or capsules.  Chemotaxis and motility are 
important for B. burgdorferi to cause infection and are considered as invasive attributes of this 
organism.  Only a handful of studies have reported that non-chemotactic and non-motile B. 
burgdorferi mutants are unable to disseminate in hosts, and are, therefore, non-infectious in 
mice.  Although motility and chemotaxis has been shown to be crucial for the infectious life 
cycle of B. burgdorferi, little is known about the mechanism of motility or assembly of 
periplasmic flagella. It is not known how incremental reductions of motility affect B. 
burgdorferi’s virulence.  Recent cryo-electron microscopy tomography revealed that spirochetes 
possess a unique flagellar structure called the collar. However, the gene or genes that encode for 
the B. burgdorferi collar proteins are unknown.  Because of its location in the periplasmic 
 
 
 
 
flagellar motor, we hypothesize that this organelle is important for flagellar assembly as well as 
motility.  We also hypothesize that less motile or less chemotactic mutants will exhibit a reduced 
invasive phenotype in vivo.  Using Bioinformatics techniques, two potential candidate genes 
were identified (bb0526 and bb0773) that may encode the collar.  These two genes are annotated 
as putative genes in the B. burgdorferi genome with no significant similarity to other bacterial 
species outside of spirochetes.  A BLAST search indicated that bb0526 has homology to an 
unconfirmed motility gene in Treponema pallidum, another spirochete. A third gene, fliZ, 
putatively encodes a regulator of the flagella assembly complex.  In other bacteria, inactivation 
of fliZ creates a reduced motile phenotype.  Two genes that are hypothesized to have chemotactic 
function are cheY1 and cheY2. Inactivation of these genes creates mutants with a phenotype 
indistinguishable from wild type in vitro.  However, they may exhibit a different phenotype in 
vivo.  In order to test our hypotheses, mutants for cheY1, cheY2, bb0526, bb0773, and fliZ were 
created.  Our results show that the Δbb0773 mutant exhibits no discernible defects with respect 
to motility or morphology; the Δbb0526 mutant is associated with the collar structure and has a 
decreased motility defect.  Inactivation of fliZ creates a mutant with a reduced number of 
periplasmic flagella and the wild type phenotype is restored upon complementation in trans.  To 
demonstrate if reduced motility or chemotaxis is important for survivability or transmission 
between hosts, we plan to assay these mutants in mouse-tick-mouse infection cycle experiments. 
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CHAPTER 1: INTRODUCTION 
1.1  Lyme disease 
 Lyme disease owes its name to  Lyme and Old  Lyme, two towns in Connecticut where 
doctors documented that children were developing juvenile rheumatoid arthritis in the early 
1970’s (1).  This arthritis was quickly recognized to be an epidemic problem as many more cases 
were reported in the mid-1970s, and not just by children, but adults as well (2, 3).  
Accompanying the arthritis were a medley of symptoms, including fever, fatigue, headache, 
myalgia, and skin rash (2).  The disease that was described in  Lyme was found to be prevalent 
throughout eastern and northeastern United States, and the incidence of this disease was cyclic 
(3).  One of the most noticeable symptoms of this disease was a bull’s eye shaped rash known as  
Erythema  chronicum migrans (3).  Such a rash had previously been seen in Europe as the result 
of the bite of a tick known as Ixodes ricinus, thus, indicating that the  Lyme disease may be 
similarly transmitted by ticks in the United States (3).   
In 1982, Willy Burgdorfer published his discovery of an Ixodes scapularis tick that was 
infected with a previously unknown spirochete of the Borrelia family.  Bites from infected ticks 
caused lesions in rabbits, and the spirochete reacted with serum of  Lyme disease patients (4).  It 
was subsequently shown that this spirochete was the causative agent of  Lyme disease and it was 
named Borrelia burgdorferi after its discoverer (5).   
The cyclic nature of  Lyme disease is due to the fact that it is a zoonotic illness.  In 
nature, B. burgdorferi resides in two disparate hosts, Ixodes ticks and small rodents (5).  Because 
of the zoonotic cycle, the rate of  Lyme disease fluctuates throughout the year.  However, it is the 
most commonly reported vector-borne illness in the United States.  The cases of  Lyme disease 
have increased considerably since 1992 (6) and it is now considered an emerging infectious 
 
 
2 
 
disease.  In 2011, there were 24,364 confirmed and 8,733 probable cases of  Lyme disease in the 
United States according to the Centers for Disease Control and Prevention (CDC) (7).   
B. burgdorferi is a Gram-negative spirochete and an obligate microaerophilic anaerobe 
(8).  It has a flat-wave morphology and ranges from 4 to 30 µm in length and has a diameter of 
approximately 0.3 µm (5).  As with other spirochetes, B. burgdorferi has two membrane layers, 
the inner and the outer membranes.  In between the outer membrane and peptidoglycan layer is 
the periplasmic space.  In this space, the flagella of B. burgdorferi are located.  The unique flat-
wave morphology is due to the wrapping of these active flagella around the protoplasmic cell 
cylinder created by the inner membrane (5).   
B31 was the first strain of B. burgdorferi to be isolated and sequenced (5).  The genome 
of B. burgdorferi is unique in several ways.  First and foremost of these is that in addition to a 
large linear 910 kb chromosome, B. burgdorferi possesses 21 extrachromosomal DNA elements 
with 12 linear and 9 circular plasmids, the most endogenous genetic elements of any bacterial 
genomes sequenced to-date.  The convention for naming these plasmids is to indicate if it is 
circular (cp) or linear (lp) and then the length of the plasmid in kilo base pairs.  For example, 
lp25 is a linear plasmid 25 kb in length.  If there are more than one of a given type and size of 
plasmid, they are numbered, such as lp28-1.  The extrachromosomal elements add an additional 
611 kb of genomic material.  In a laboratory setting, there are 11 plasmids that are dispensable 
and B. burgdorferi will survive in artificial media without them.  Six of these, cp9, cp32–3, lp21, 
lp28–2, lp28–4, and lp56, are also dispensable for growth in vivo (9).  Two plasmids, lp56 and 
lp25, harbor restriction modification enzymes, thus their presence creates challenges for genetic 
modification (10).  Several plasmids, such as lp28-1 and lp25, are required for infection and 
persistence in the host and their loss during cultivation in vitro attenuates the bacteria (11).  
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Another uncommon feature of bacterial genomes is pseudogenes –B. burgdorferi has 167 such 
genes (12).   
The optimal growth conditions for B. burgdorferi are 34°C to 37°C in a 2-3% CO2 
humidified incubator.  B. burgdorferi is a relatively slow-growing bacterium with a doubling 
time of 5 to 12 hours at optimal conditions (5).  The organism’s relatively small genome size 
indicates that B. burgdorferi lacks many metabolic pathways and therefore it is considered as a 
fastidious bacterium and must be grown in vitro in complex, nutrient rich “Barbour-Stoenner-
Kelly II” media (BSK-II).  The constituents of this media are: CMRL 1066, neopeptone, bovine 
serum albumin (Fraction V), yeastolate, N-2-hydroxyethylpiperazine, N-2-ethanesulfonic acid, 
glucose, sodium citrate, sodium pyruvate, N-acetylglucosamine, sodium bicarbonate, and rabbit 
serum (13).  It was designed to emulate B. burgdorferi’s natural tick and mammalian host 
environments (13).   
B. burgdorferi is a highly mobile and invasive pathogen (14).   Genome sequence 
analysis suggests that B. burgdorferi lacks common virulence factors such as toxins or 
lipopolysaccharide but contains large numbers of lipoproteins (6-7% of total genome) that induce 
host inflammation (15).  Despite formidable challenge in genetic manipulations, recent reports 
indicate that B. burgdorferi  virulence factors that contributed to either infection in experimental 
mice or survivability in ticks, or both, are: complement inhibition, decorin, fibronectin, 
plasminogen, laminin and integrin binding proteins, outer surface proteins (e.g., OspA, OspB, 
and OspC), VlsE which undergoes antigenic variations during mammalian infection, c-di-GMP 
metabolizing proteins, and many more (16).   Moreover, although only a few studies have been 
reported, their results indicate that chemotaxis and motility are important for infection as well as 
transmission from ticks to naïve mice (17-19).   
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Since its discovery, much has been learned about the progression of  Lyme disease.  
There are three stages of a B. burgdorferi infection, but it is possible to have symptoms of any 
stage out of order (20).  Because of the lack of definite progression and vague symptoms, 
misdiagnosis is common (21).   
Stage I is the first stage in a  Lyme disease infection (20).  Patients with a stage I 
infection have a wide range of symptoms such as malaise, fatigue, headache, fever, chills,  stiff 
neck, arthralgias, myalgias, lymphadenopathy, and other less common symptoms (22).  Stage I 
can last for weeks after the initial B. burgdorferi infected tick bite and is said to be over when the 
symptoms become more severe (20).  In 70-80 percent of the cases,  Erythema  chronicum 
migrans presents 2 to 32 days after infection, making it a good clinical indicator of infection 
(22).  Often the  Erythema migrans shows a ‘bull’s eye pattern around the tick bite site, but the 
rash can show up anywhere and it can vary in shape, size, and location (23).  The rash is caused 
by peripheral lymphocytic and eosinophilic infiltration of cutaneous vessels as they attempt to 
contain the Borrelial infection (24, 25).   Lyme disease patients that go untreated can have a 
recurrence of  Erythema migrans 1 to 14 months later (20). 
As the spirochetes disperse through the body tissue, weeks or months after the initial tick 
bite, stage II infections are said to start (20).  Neurological symptoms such as meningoradiculitis, 
which is inflammation of the meninges and the cranial or spinal nerve roots, can occur resulting 
in peripheral and central nervous dysfunction due to lymphocytic infiltration.  Some of the major 
manifestations of the neural symptoms are insomnia, photophobia, and facial palsy (22).  Some 
patients also develop new cutaneous symptoms at this point (20).  At this stage,  Lyme carditis is 
also possible (20).  This carditis manifests most often as atrioventricular blockage due to 
inflammation, the presence of the spirochete, or both (26).   
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Stage III of  Lyme disease starts six months after the initial tick bite.  This is based on 
time alone, and not symptoms (20).  The neurological symptoms become more severe, as do the 
skin and cardiac conditions.  The skin begins to atrophy, with a condition called acrodermatitis 
chronica atrophicans of Herxheimer (20).  Cardiac problems develop in approximately one 
percent of patients, but can lead to death (27).     
A common symptom at this point is  Lyme arthritis, which is characterized by 
asymmetric swelling of a joint, sometimes accompanied by pain.   Lyme arthritis comes in two 
forms: intermittent arthritis, which is characterized by spells of arthritis followed by arthritis-free 
periods, and chronic arthritis, which lacks the arthritis-free periods.  The CDC reports that 33 
percent of all  Lyme disease patients report arthritis (7).  When untreated by antibiotics, 62 
percent of patients of one study developed  Lyme arthritis (28).  The most common site of  Lyme 
arthritis is the knees, followed by the shoulder and back (28).   
Antibiotic refractory patients continue to exhibit symptoms even after a seemingly 
successful treatment of antibiotics.  In one study, children with  Lyme arthritis were treated with 
antibiotics and 23% of those children became antibiotic refractory (29).  The antibiotic refractory  
Lyme arthritis may be caused by infection-induced autoimmunity, retained spirochete antigens, 
or both.  This has led researchers to search for another mechanism to cause the symptoms, such 
as molecular mimicry.   OspA, a B. burgdorferi outer-surface protein, shares an epitope (amino 
acids 163-175) with the human histocompatibility leukocyte antigen (hHCL) DR4-A.  The hHCL 
DR4-A is used by the immune system to recognize cells as ‘self’ (30).  It is possible that 
antibodies against OspA are reacting with hHCL DR4-A, causing the inflammation that results in  
Lyme arthritis (30).  
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 There are many antibiotics that can cure stage I and stage II  Lyme disease.  For example, 
treatment of tetracycline over a period of 10 days cures  Lyme disease quite well (31).  
Currently, there is no vaccine available for  Lyme disease.  A vaccine against recombinant OspA 
was pulled from the market for humans in 2002 due to low demand (32).  OspA is an outer 
membrane surface protein that is up-regulated when B. burgdorferi is in the tick midgut, and 
then down-regulated when the tick begins feeding (33) .  A similar vaccine, but using OspA and 
OspB, is available for dogs.  OspB is also up-regulated when B. burgdorferi is in the midgut of 
the tick (34). 
1. 2 The Ixodes family of ticks 
It is through the bite of the Ixodes family of ticks that B. burgdorferi transmits between 
arthropod and vertebrate hosts (rodents are the primary reservoir).  B. burgdorferi is an obligate 
pathogen (35).  The vertebrate hosts are generally thought to be mammals, but birds, and even 
lizards can be hosts for B. burgdorferi (36, 37).  In the eastern and northeastern part of the 
United States, Ixodes scapularis is the competent host of B. burgdorferi, and in the western part, 
it is Ixodes pacificus.  In Europe, Ixodes ricinus is the predominant carrier of the spirochete (16).  
The life cycle of the tick plays an important role; without it, the bacteria could not be transmitted 
to its vertebrate hosts.  The Additionally, this knowledge of this cycle is important for humans, 
as the tick is more likely to transmit B. burgdorferi at certain stages of its life cycle (38). 
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The Ixodes genus of ticks has a general life cycle to which they adhere (38, 39)  (Figure 
1).  Ticks hatch from eggs as larvae.  At this larval stage, the ticks are not infected with B. 
burgdorferi as transovarial transmission is absent in ticks (16, 40).  In order to survive and 
acquire the spirochete, the larvae must take a blood meal in small vertebrates, such as mice and 
squirrels.  If a tick’s first host is infected with B. burgdorferi, then the ticks can also acquire the 
Figure 1:  The life cycle of the I. scapularis.  The diagram shows the cycle starting with 
the female ticks laying eggs.  The newly hatched ticks will remain in the larval stage for a 
year.  After taking a blood meal, it will molt into a nymph.  The nymph aggressively looks 
for a blood meal, after which, it will molt into an adult.  The adult will mate and lay eggs 
and the cycle starts over.  Figure 1 is adapted from reference (16).   
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infection from the host’s blood that they ingest (40, 41).  Once they acquire the infection, the 
spirochetes survive in the tick until it dies. 
After their first blood meal, larvae molt into their next developmental stage, nymphs (16).  
The nymph will search for a second blood meal from an expanded list of hosts from that of the 
larvae, which includes slightly larger animals.  It is at this stage that Ixodes ticks pose the 
greatest threat of transmitting B. burgdorferi to humans because of their possibility of being 
infected and their increased range of hosts (42).  After feeding, the nymphs molt for a season, 
during which time they become adults (43).  The adults prefer deer as their host, and it is on that 
host that they mate (41).  After mating, the male dies and the adult female tick lays eggs.  The 
cycle continues when the eggs hatch (39, 43). 
 
1.3 Movement of B. burgdorferi 
Motility is well characterized in Escherichia coli, thus it is a good model to which we can 
compare B. burgdorferi.  E. coli is a motile organism with 5-7 peritrichous flagella per cell that 
extend out from the cell about 5 µm into the extracellular environment.  Their flagella are helical 
and about 13.5 nm in diameter.  Rotation of flagellar motors turns the flagella, enabling bacteria 
to propel themselves through liquid media (44).   When E. coli cells sense a chemo attractant, 
they will turn their flagella in a counter-clockwise motion, causing them to run in a straight line.  
However, when they sense a repellant, or no longer sense an attractant, they will switch the 
direction that the motors spin.  When the flagella spin clockwise, the cells tumble (45).  
Tumbling allows the cells to swim in a new direction.  The flagella are more dynamic than 
originally thought; it seems that the flagella do not move in synchrony.  In some cases, it can 
take as little as one flagella moving clockwise to throw the cell from its smooth run (46).   
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All members of the phylum spirochaete can be identified by a helical shaped cell.  In 
contrast to E. coli, no flagella can be seen protruding from the cells into the extracellular space.  
This is due to the location of flagella in spirochetes; the flagella are in the periplasmic space 
(Figure 2A, B) (14).  In B. burgdorferi, between 7 and 11 periplasmic flagella are anchored to 
each cellular pole forming a ribbon-like structure (47).  The periplasmic flagella extend away 
from the poles of the cell, wrapping around the protoplasmic cell cylinder towards each other.  
The periplasmic flagella are crucial for B. burgdorferi’s flat-wave morphology and motility (48).  
The flaB gene encodes the subunits that make up the major flagellar filaments (49).  When flaB 
is inactivated, B. burgdorferi cells become rod-shaped and immobile, and are unable to establish 
infection in mice.  This demonstrates the key role of the periplasmic flagella in the morphology, 
motility, and virulence of B. burgdorferi.  Additionally, ticks artificially infected with the non-
motile mutants failed to transmit the spirochetes into naïve mouse (19, 48).    
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B. burgdorferi is an agile bacterium.  While E. coli has only two swimming modes, B. 
burgdorferi has three swimming modes—it can swim forward, reverse, and flex (flexing is 
thought to be equivalent to tumbling).   When the two ribbons of flagella, located one on each 
pole, spin with the same direction of rotation, the cell will flex.  However, due to the left-handed 
helical shape of B. burgdorferi, when the periplasmic motors at the poles of the cell spin in 
opposite directions, the cell will swim in the direction of the pole that is spinning counter-
clockwise (50).  This asynchronous movement of the flagella seems to be a more complex 
chemotactic system than that of E. coli.  B. burgdorferi does not favor swimming towards one 
pole over the other.  It will reverse constantly and seemingly at random (51).  
Figure 2. Schematic of periplasmic flagella.  a) This graphic illustrates the location of the 
flagella in Borrelia burgdorferi.  The flagella are internal to the outer membrane, but 
external to the protoplasmic cell cylinder.  b) This cutaway graphic shows the periplasmic 
space in which the flagella filaments are located (92). 
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1.4 Chemotaxis Pathway of  Escherichia coli 
 The chemotaxis pathway in E. coli, which allows it to sense a gradient in chemical 
attractants and repellents (52), is one of the most well studied in the bacterial domain.  The 
signaling system has been studied since it was first elucidated in the 1970’s (53).  Because it is 
so well known, we will use its chemotaxis system as a model to understand B. burgdorferi 
chemotaxis.    
E. coli’s chemotaxis begins with the methyl-accepting chemotaxis proteins or MCPs 
(Figure 3) (53).  MCPs are 40-65 kilodalton proteins that are embedded in the cytoplasmic 
membrane as dimers (54).  E. coli has 5 MCP’s, each for sensing different ligands in the 
environment (55).  When the amino terminus of an MCP binds ligands in the periplasm, it 
undergoes a conformational change, sending a signal across the cytoplasmic membrane to the 
carboxyl terminus (55).   
On the cytoplasmic side of the inner membrane, the MCP binds CheW and CheA.  CheA, 
which is a dimer, functions as a histidine kinase (56).  CheW functions as bridge between the 
MCP and CheA (Figure 3) (57).  CheW transmits the signal with a conformation change from 
the MCP to CheA.  A sensory subunit on CheA, which senses the signal from CheW, will then 
phosphorylate a neighboring subunit on CheA which is a histidine kinase (56).  Mutants in either 
cheW or cheA will have flagella that only spin counter-clockwise, which will cause the bacteria 
to swim continually without tumbling (58).    
After CheA auto-phosphorylates, CheA-P transmits its signal to a cognate response 
regulator CheY (59).  In E. coli, CheY is a small, single domain protein.  The phosphate is 
removed from CheA-P and placed preferentially on CheY’s aspartate residue 57 (60).  CheY, 
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upon phosphorylation, binds flagellar switch protein FliM, which is located at the base of the 
flagellar motor complex (Figure 3) (61). It is through FliM that the signal will be translated into 
physical action, ultimately causing the flagella to spin clockwise and the cell to tumble (61).   To 
terminate the signal, CheY-P auto-dephosphorylates or a phosphatase, CheZ, binds to and 
dephosphorylates it with high affinity.  This resets the signal back to default, and the flagella turn 
counter-clockwise (run) again.  Both CheZ and FliM compete for the same position at the C-
terminus of phosphorlyated CheY (62).   Because CheY deficient mutants are unable to 
transduce the signal to tumble, the cell will continue on in the default swimming mode. 
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  CheB is a methylesterase that catalyzes the hydrolysis of γ-glutamyl methyl ester 
residues on the MCPs, resulting in the release of methyl groups in the form of methanol.  CheB 
 Figure 3: Graphical representation of the chemotaxis protein indicating their position 
and relative size in Escherichia Coli. The MCP sends a signal through CheW to CheA.  
CheA then phosphorylates CheY, which is the response regulator, moving the signal to 
the flagella at FliM.  In this case, the ligand has just been released, so the 
phosphorylation of CheA and CheY occurs (98). 
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is phosphorylated by CheA-P, which activates it.  CheR is the antipode to CheB.  CheR is a 
methyltransferase that only methylates membrane bound MCPs (63).  This is part of the 
environmental sensory adaption system, as the methyl-groups decrease the efficiency of ligand 
binding by the MCP (64).  While CheB is removing methyl groups from an MCP, CheR is 
replacing them back on the MCP (Figure 4).  Deletion mutations in cheR cause counter-
clockwise flagella rotations so that the cell will swim continuously, without tumbling (58).  A 
mutant that is unable to produce functional CheB will constantly tumble, indicating that the 
removal of the methyl groups activates the MCP and starts signal transduction (58).   Different 
MCPs can carry different amounts of methyl groups.  For example, MCPI can carry six, but 
MCPIV carries up to four (64). 
 
 
 
 
 
 
Figure 4:  Graphical representation of the relationship between the MCP/CheW/CheA 
structure and the methyl group manipulation of CheR and CheB.  When an attractant is 
bound and the MCP is methylated, CheA will not be active and the flagella will turn 
counter-clockwise and the cells run (97). 
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1.5 Chemotaxis pathway of  B. burgdorferi 
Chemotaxis is hypothesized to be a virulence-associated factor of B. burgdorferi.  More 
than one report indicates that chemotaxis is important for this spirochete’s pathogenesis (14, 17).  
As mentioned earlier, B. burgdorferi deviates from E. coli in several important ways in its 
swimming modes and cellular structure.  There are also some differences in their chemotactic 
pathways.  A more complex chemotactic system would be expected from B. burgdorferi.  This 
expectation is realized with genomic analysis revealing that B. burgdorferi has more than one 
copy of several chemotactic genes: two cheA, three cheW, three cheY, two cheB, and two cheR.  
Some of these homologues still have unknown functions (65). B. burgdorferi does not encode a 
homologue for phosphatase CheZ but instead possess a CheX (66). 
 B. burgdorferi has five putative methyl-accepting proteins, named MCP1-5, located on 
the genome at: bb0578, bb0596, bb0597, bb0680, and bb0681, respectively (15).  MCP3 and 
MCP5 share homology with the most abundant E. coli MCPs (tar and tsp) (67).  By tagging 
these proteins with green fluorescent proteins and immunofluorescence assays, it has been shown 
that B. burgdorferi MCPs cluster near the periplasmic flagellar motors at the poles of the cells.  
This localization may help in the speed of signal transduction from the MCPs to the flagella 
motors (68).   
 Genes which encode proteins that work in collaboration are often clumped together in the 
same operon.  One such operon in B. burgdorferi pertaining to chemotaxis consists of the 
following genes: flaA (bb0668), cheA2 (bb0669), cheW3 (bb0670), cheX (bb0671), cheY3 
(bb0672).  All of the genes in this operon have chemotaxis related functions, except flaA, which 
encodes a subunit that makes up the outer layer of the periplasmic flagella filament (69) .  When 
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a loss-of-function mutation occurs in cheA2, cheX, cheY3, or cheW3, the result is non-
chemotactic bacteria  (60, 66, 70, 71). 
CheA2 of B. burgdorferi functions similar to that of E. coli in that it is a histidine kinase 
that binds nucleotides.  A loss-of-function mutation in this cheA2 results in a phenotype that 
constantly runs, whereas a loss-of-function of cheA1 has no discernible phenotype (60). CheA2 
is an 864-amino-acid protein that shares 35.5 percent similarity with the E. coli CheA (15).  
Using immuno-precipitation assays, CheA2 has been shown to associate with both CheW1 and 
CheW3 and CheA1 has been shown to associate with CheW2 (70).  Another difference between 
B. burgdorferi and E. coli is that CheW3 is almost three times bigger than E. coli’s 18 kD CheW 
(72), (73).  Based on the results, it appears that when the MCP undergoes a conformational 
change, CheW3 transduces the signal to CheA2, which auto-phosphorylates and then 
phosphorylates CheY3 (66). CheX then dephosphorylates CheY3-P (66, 71). 
 B. burgdorferi has three cheY genes with homology to E. coli’s cheY: cheY1, cheY2, and 
cheY3. The B. burgdorferi cheY genes are numbered in order of their locus number; cheY1 is 
locus bb0551, cheY2 is bb0570, and cheY3 is bb0672 (74).  The functional residues of the CheY 
molecule of E. coli are conserved within the three B. burgdorferi CheY molecules (Figure 5).  In 
a non-virulent strain of B. burgdorferi (B31A), cheY1 and cheY2 mutants showed normal 
swimming motility and chemotactic response using capillary tube and swarm plate chemotaxis 
assays (74).  cheY3 mutants, on the other hand, exhibited a significantly reduced chemotactic 
response (74).  While it was reported that all three CheYs were able to be phosphorylated by 
CheA1-P or CheA2-P, only CheY3-deficient B. burgdorferi exhibited a phenotype that differed 
from wild type in vitro (74).  Taken together, this evidence indicates that CheY3 is the main 
chemotactic response regulator under the conditions tested.   
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 While there is currently a strong effort to study genetics of spirochete chemotaxis, still no 
model exists for the actual mechanics related to the independent movement of the periplasmic 
flagella at each poles. 
 ΔcheY3 mutants are non-chemotactic in vitro.  Their phenotype is that of constantly 
running cells (71).  While we hypothesize that these cells would be non-virulent, there is no data 
to conclusively demonstrate this.  When the other two cheY genes are inactivated, the cells 
display a wild type level of motility and chemotaxis in vitro.  However, cheY1 and cheY2 express 
in growing B. burgdorferi and as indicated above, they are also phosphorylated by the histidine 
kinases, thus we predict that cheY1 and cheY2 could function in vivo.  In a pilot transposon 
Figure 5. T-Coffee amino acid sequence alignments of CheY molecules from B. 
burgdorferi, E. coli, and Bacillus subtilis.  Circles indicate conserved residues that are 
essential for function in E. coli. The triangles indicate active-site residues of E. coli CheY, 
N59 and E89, which are conserved in B. burgdorferi CheY2, but not in CheY1 or CheY3.  
Secondary structures for E. coli CheY, which are expected for B. burgdorferi CheY 
proteins, are above the sequence alignment. The E. coli and B. subtilis CheY proteins are 
denoted as Ec-CheY and Bsu-CheY, respectively. Indicated on the left are amino acid 
residue numbers (74). 
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mutagenesis study, a cheY2 mutant was shown to be necessary for viability within a mouse (75).  
It is not known whether ΔcheY2 mutants can survive in the ticks or if they are important for 
transmission from the tick to the mouse.  As we believe that cheY1 and cheY2 have a function in 
vivo, we want to use mutants of these genes in a tick-mouse cycle experiment to determine, if 
they have function at a particular point in the cycle.    
1.6 Flagellar Structures  
The chemotaxis signal is transferred into physical motion at the stator in the flagella 
apparatus.  The stator in Borrelia burgdorferi is made up of MotA and MotB.  These proteins are 
predicted to contain transmembrane domains (76).  Cryo-electron tomography (cryo-ET) 
confirms that the stator forms a ring around the rotor at the cytoplasmic membrane and is directly 
external to the C-ring.  The stator is the motor that turns the rotor (77) (Figure 6).   
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In between the rotor and the stator is a protein, FliL, which may be involved in flagellar 
orientation (74).  The rotor is made up of the C-ring (FliG, FliM, FliN).  At the distal end of the 
rod is the hook protein (FlgE), from which the flagellum extends, wrapping around the body of 
the cell (78).  When the stator rotates the rotor, the hook turns with it, thereby spinning the 
periplasmic flagella (FlaA and FlaB).   
Figure 6. 3-D model of the basal body of a B. burgdorferi flagella motor based on Cryo-
ET images.  This model shows the export apparatus at the base of the basal body, on 
which sits the MS ring.  These are surrounded by the C-ring and the stator.  On top of the 
MS ring are the rod and the P-ring, which are surrounded by the collar (80). 
 
 
 
21 
 
1.7 The Collar Structure 
Sitting on top of the stator and extending through the peptidoglycan layer is a 
predominant structure known as the collar (Figure 7).  This collar wraps around the p-ring, which 
is thought to act as a bushing for the rod as well as help maintains the periplasmic flagellar 
normal orientation toward the cell body (77).  The collar structure, though appearing circular, 
actually creates more of an ellipsis shaped ring around the p-ring (figure 21B) (79).  The 
narrowest diameter is 35 nm and the longest diameter of the elliptical ring created by the collar is 
38 nm (79).  The elliptical shape is most likely due to curvature of the membrane in which the 
flagella motor is embedded (79).  The collar appears to be connected to the MS ring and the 
stator.  This structure is unique to spirochetes and its exact function is unknown (80).  The gene 
or genes coding the collar structure have not been identified yet.  We plan to find these genes 
through Bioinformatics techniques.  By comparing the B. burgdorferi genome to suspected genes 
known from the literature, we plan to discover the genes encoding the collar structure and 
confirm this through gene inactivation and cryo-ET.   
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1.8 Flagellar Assembly 
Most of the flagellar genes are located in a large 27 gene flgB operon (81).  The majority 
of these genes have been or are being characterized in our laboratory, however fliZ has yet been 
characterized. These genes encode the export apparatus (fliP, fliQ, fliR, flhA, and flhB), the C-
ring (fliG, fliM, and fliN), and the stator (motA, and motB).  fliZ is located in the middle of this 
flgB operon.   In Salmonella, the homolog for the B. burgdorferi fliZ is called fliO (82).  While 
FliZ shares only 28% amino acid sequence identity with FliO in Salmonella enterica serovar 
Typhimurium str. D23580’s, the functional domains of FliO are conserved in FliZ (67).  In S. 
enterica, a deletion of fliO creates a severely slow mutant.  When fliO is inactivated, the motile 
phenotype can be saved by constitutive expression of fliP.  This indicates that fliO is a regulator 
of fliP (83).  It is our hypothesis that we would see a similar slow mutant in B. burgdorferi.
Figure 7. Cryo-ET image of the cross-section of the basal body of B. burgdorferi.  The collar 
structure is indicated by the orange ellipsis.  Image created by Jun Liu and Xiaowei Zhao 
from the University of Texas at Houston. 
 
 
CHAPTER 2: MATERIALS AND METHODS 
2.1 Bacterial strains and growth conditions 
Two strains of Borrelia burgdorferi were used in this study: high-passage avirulent B. 
burgdorferi strain B31A and low-passage, virulent B. burgdorferi strain B31A3.  The main 
difference between these is that the virulent B31A3 strain contain all 21 plasmids except a 9 kb 
circular plasmid (cp9), whereas the B31A strain has lost 11 plasmids.  Both strains have the 910 
kb chromosome (12).    Two strains are used rather than just one, because the avirulent strain is 
genetically more malleable and durable for in vitro experimentation than the virulent strain.  B. 
burgdorferi was grown in BSK-II medium at 35
o
C in an incubator with 2.5% CO2.  Plating 
BSKII (P-BSKII) medium was prepared with 0.6% agarose (84).  
2.2 cheY2 inactivation 
To inactivate cheY2, we PCR amplified a 1494 bp section of genomic DNA using Dream Taq po 
Lymerase (Fermentas Inc.) using primers, TCTGCTAGGTTTCAAAATAT  (Y2-KO-F-2) and 
TGGACTTACCCT TTACATAG (Y2-KO-R-2). This fragment encompassed a 658 bp section 
upstream of cheY2, a 493 bp section downstream of cheY2, as well as the 375 bp cheY2 gene.  
The 1494 bp fragment was inserted into pGEM®-T Easy vector system using TA cloning, and 
then restriction digested with HindIII in order to ligate a kanamycin antibiotic resistance cassette.  
An aph1 (encodes kanamycin resistance) gene was fused to the B. burgdorferi flgB promoter 
(PflgB-aph1) in order to express the resistance gene in B. burgdorferi which was then inserted into 
HindIII site of the target gene.  The orientation PflgB-aph1 is in the same direction as the 
transcription of the target gene (Figure 8).   
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A         
B 
C 
D 
E 
Figure 8. Schematic representation of the construction of ΔcheY2-Easy plasmid.  A) Step 1: 
Amplify fragment of genomic DNA encompassing cheY2 (the blue arrows represent location 
of primers used for this step). B) Step 2: Insert fragment into pGEM-T Easy vector.  C) Step 
3: Restriction digest at the HindIII site.  D) Ligate PflgB-aph1 to the HindIII.  E)   Completed 
plasmid.  Step 5: Digest the plasmid with NotI and use the linearized cheY2-PflgB-aph1 DNA 
to electroporate in competent B. burgdorferi. 
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The plasmid, ΔcheY2-Easy, was transformed into E. coli strain JM109 and then isolated 
from single colonies using Wizard® Plus Midipreps DNA purification system (Promega Inc.).  
80 µg of the purified plasmids were digested with NotI, ethanol precipitated, and rehydrated in 
15 µL of nuclease-free dH2O.   The resulting linear DNA was used for electroporation into 
competent B. burgdorferi B31A3 cells and allowed to recover overnight.  The electroporated 
cells were diluted in 100 milliliters of BSK-II with 200 µg/ml of kanamycin and plated in 96-
well plates with 200 µl of media per well. Plates were incubated for 2-4 weeks in an incubator.  
A color change in the wells indicated kanamycin resistant bacterial growth.  Some of the 
randomly picked clones were grown in 3 ml BSKII, and 1.5 milliliters of the culture was mixed 
with 0.5 milliliters of glycerol and frozen at -80
o
C for stock.    The remaining 1.5 milliliters was 
used for extraction of genomic DNA using Promega’s PureYield™ Plasmid Miniprep System.  
This DNA was used for genotyping as well as checking retention of endogenous plasmids by 
PCR.  Genotyping was conducted with the primers used in the creation of the plasmid, (Y2-KO-
F-2) and (Y2-KO-R-2).  This genotype was also confirmed with a primer that binds to the aph1 
cassette, TGTTTCTGAAACATGGCAAAGGTAG (BKAN-1), and a primer that binds to a 
small portion of cheY2 that was not deleted, GATGACAATAGGGCA ATAAG (Scr-CheY2-F).  
Once a clone is confirmed as mutant, endogenous plasmids were detected using previously 
described primers (9).  Retention of those plasmids is important for infection and persistence in 
the host (12).  Additionally, western blotting using specific antisera was also used to confirm the 
inhibition of CheY2 protein in the mutant cells (see below). 
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2.3 cheY1 inactivation 
To inactivate cheY1 (381 bp gene), a 2292 bp section of B. burgdorferi genomic DNA 
was PCR-amplified using Taq DNA Po Lymerase and primers, 
GCAGTTGTTTTATGACATTGTC (Y1-KO-F-Big)  and ATCTTGTCGGAAAACCCTTC (Y1-
KO-F-Big). This DNA fragment encompassed cheY1 as well as a 1569 bp upstream and a 342 bp 
downstream of cheY1.  The PCR amplified DNA was inserted into pGEM®-T Easy Vector.  A 
273 base pair section was deleted from cheY1 using two HindIII sites within the cheY1 gene.  A 
PflgB-aph1 cassette was then inserted between the HindIII sites within the cheY1 gene oriented in 
the same direction as the target gene creating the pGEMT-∆cheY1 plasmid (Figure 9).   
  A
C
V
V
A 
 Figure 7. Schematic representation of the construction of ΔcheY2.  A) Step 1: Amplify fragment of 
genomic DNA encompassing cheY2 (the blue arrows represent location of primers used for this 
step). B) Step 2: Insert fragment into Promega’s pGEM®-T Easy vector.  C) Step 3: Cut the HindIII 
site.  D) Ligate PflgBaph1 (kanamycinR) to the sticky ends.  E)   Completed plasmid.  Step 5: 
Electroporate plasmid into wild-type B. burgdorferi  to inactivate cheY2 by homologous 
recombination. 
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Figure 9. Schematic representation of the construction of ΔcheY1 plasmid.  A) Step 1: 
Amplify fragment of genomic DNA encompassing cheY1 (the arrows represent location 
of primers used for this step). B) Step 2: Insert fragment into pGEM-T Easy vector.  C) 
Step 3: Digest at the HindIII sites and ligate PflgB-aphI to the same sites.  C) Completed 
plasmid, pGEMT-∆cheY1.   
C
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A 
 Figure 7. Schematic representation of the construction of ΔcheY2.  A) Step 1: Amplify fragment of 
genomic DNA encompassing cheY2 (the blue arrows represent location of primers used for this 
step). B) Step 2: Insert fragment into Promega’s pGEM®-T Easy vector.  C) Step 3: Cut the HindIII 
site.  D) Ligate PflgBaph1 (kanamycinR) to the sticky ends.  E)   Completed plasmid.  Step 5: 
Electroporate plasmid into wild-type B. burgdorferi  to inactivate cheY2 by homologous 
recombination. 
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 Figure 7. Schematic representation of the construction of ΔcheY2.  A) Step 1: Amplify fragment of 
genomic DNA encompassing cheY2 (the blue arrows represent location of primers used for this 
step). B) Step 2: Insert fragment into Promega’s pGEM®-T Easy vector.  C) Step 3: Cut the HindIII 
site.  D) Ligate PflgBaph1 (kanamycinR) to the sticky ends.  E)   Completed plasmid.  Step 5: 
Electroporate plasmid into wild-type B. burgdorferi  to inactivate cheY2 by homologous 
recombination. 
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We electroporated the pGEMT-∆cheY1 plasmid into competent, virulent B. burgdorferi stain: 
B31A3 cells.   Transformants were genotyped using the primers used in creation of the plasmid 
as described before.  Retention of endogenous plasmids was checked by PCR to ensure that these 
cells were virulent. 
 
2.4 bb0526 inactivation 
 In order to make the bb0526 mutant, a 4251 base pair section of wild type genomic DNA, 
centered on bb0526 (1824 bp), was amplified using DreamTaq po Lymerase and the following 
primers ACTAGGCTTGCATTAAGTGG (bb0526-KO-F) and GGCCTTATACTTTGAAAACC 
(bb0526-KO-R).   This genomic DNA included a section 1568 base pairs upstream and 1510 
base pairs downstream.  This section was inserted into pGEM®-T Easy Vector.  Within the 
bb0526 gene, there are two HindIII sites, which were used to restriction digest a 1161 base pair 
section out of the gene.  In place of this section we inserted promoterless aph1 (also confers 
kanamycin resistance) (Figure 10) (85).    
A 
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Wild type genome 
 
 
 
 
 
 
 
 
 
 
Mutants were made in both strains, B31A and B31A3.  For genotyping, the entire 
construct was amplified by PCR with bb0526-KO-F and bb0526-KO-R.  Plasmid retention was 
checked for the mutants in B31A3 strain. 
 
D 
C 
B 
Figure 10. Schematic representation of the construction of Δbb0526 vehicle.  A) Step 1: 
Amplify fragment of genomic DNA encompassing bb0526 (the arrows represent location 
of primers used for this step).  B) Step 2: Insert fragment into Promega’s pGEM®-T Easy 
vector.  C) Step 3: Restriction digest the HindIII sites and ligate PflgB-aph1 to the plasmid at 
the HindIII sites.  C) Completed plasmid, pGemT-∆bb0526.   
D 
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2.5 Complementation of bb0526 in cis 
Complementation of the bb0526 mutant was done by genomic reconstitution.  The 
complementation vehicle was created by joining three fragments: parts 1, 2, and 3 (Figure 11).  
Using primers GGCCTACTTTTCTTTTGTAGG (bb0526Comp P1F) and 
ACCGGTACAAATATTTCAATTAACAAAC (bb0526Comp P1R), part 1 was amplified as a 
section of B. burgdorferi genomic DNA which included bb0525, bb0526 and bb0527, (Figure 
11A) using Expand Long Template PCR System (Roche Inc.).  The second primer engineered an 
AgeI site at the end of bb0527.  Part 1 was inserted into TOPO® XL PCR Cloning Kit (Figure 
11B).  Using primers ACCGGTCTTCAAGGAAGATTTCCTAT (bb0526Comp P2F) and 
AACTTTAAAAGACGTCATTATTTGCCGAC (bb0526Comp P2R), part 2 was amplified from 
an aadA (spectinomycin and streptomycin resistance) cassette (Figure 11C).  The primers of part 
2 engineered an AgeI site upstream and an overlapping region with fragment 3 downstream 
(Figure 11D).  Part 3 was amplified from B. burgdorferi genomic DNA downstream of the 
bb0526 using these primers: CTTTTAAAGTTTTAAATTTTTTTGTTAAATAAAT 
(bb0526Comp P3F) and CTGCAGGTGAATAATCTTAAAGACAAG (b0526Comp P3R).  
These primers engineered overlap with part 2 on one side and a PstI site on the other 
(downstream) end (Figure 11D).  Part 2 and part 3 were connected using overlapping PCR and 
this overlap product was inserted into pGEM®-T Easy Vector (Figure 11E).  The AgeI and PstI 
sites were used to digest the overlap fragment (part 2 and part 3) product from the vector (Figure 
11G).  Part 1 was then restriction digested with AgeI and PstI (Figure 11F) and into these sites 
we inserted the overlap fragment.  
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The completed plasmid was used to electroporate into bb0526 mutants in B31A and 
B31A3 and selected for with streptomycin.  Resistant colonies were isolated for genotyping.  
Primers AACTTAAATATATTTTTTTTAAAAGAT (Rbb0526 F) and 
Figure 11. Schematic representation of the construction of Δbb0526 complementation 
vehicle.  A) Step 1: Amplify part 1 fragment from genomic DNA encompassing 
bb0526 and bb0527 (the blue arrows represent location of primers used for this step).  
The reverse primer has an AgeI engineered into the tail.  B) Step 2: Insert fragment 
from the previous step into TOPO® XL.  C) Step 3: Amplify fragment of genomic 
DNA encompassing bb0528 (part 3) and PflgB-aadA (part 2) (the blue arrows represent 
location of primers used for this step). The primers used in this step were engineered to 
add an AgeI site upstream of PflgB-aadA and a PstI site downstream of bb0528.  D) 
Using overlapping PCR, join the PflgB aadA fragment and the bb0528.  E) Insert the 
fused fragment into pGEM®-T Easy Vector.  F) Cutting at the engineered sites, remove 
the fused fragment from pGEM®-T Easy Vector and cut the previous plasmid with the 
same enzymes.  G) Ligate the fused fragment into the TOPO® XL fragment for a 
finished product, To oXL-bb0525
+
.   
 
Completed plasmid.   
 
 
32 
 
TTATTCATAAATATTTATTTTTTTTGC (Rbb0526 R) were used to differentiate between 
wild type/complement and mutant bb0526.  Primers b0526Comp P2F and b0526Comp P3R were 
used to determine the presence of the aadA.  In the B31A3 strain, endogenous plasmids were 
confirmed as previously described. 
2.6 Inactivation of fliZ 
The fliZ mutant was made by replacing fliZ (bb0276; 676 bp) with a promoterless aph1 
cassette using overlapping PCR from three PCR products (Figure 12).  Part one amplified from 
upstream of fliZ using CATTTCTGTAGGGGGAACTATTTGAGC (fliZ-P1F) and 
ATTAAAACTAAAAATGAATAATAATAGTTA (fliZ-P1R).   Part two was amplified from 
promoterless aph1 cassette and was engineered with overlapping regions on each parts one and 
three using primers ATCTATCTTTTAGAAAAACTCATCGAGCATC  (fliZ-KOF) and 
TGAATAATAATAGTTAAAAGCAATTTTAAATG (fliZ-KOR).  Part three was amplified 
from genomic DNA downstream of fliZ using primers 
TTTTCTAAAAGATAGATTAAAAAAATTTTAG (fliZ-P2F) and 
GGCAAAGATATCATCACAGGGGGCAAC (fliZ-P2R) (Fig. 12A).  Using overlapping PCR 
and primers fliZ-P1F and fliZ-KOR, the first part was joined to the second (Fig. 12B).  The 
joined segments were then connected to the third part using primers fliZ-P1F and fliZ-P2R.  The 
final 2423 bp product was then inserted into pGEM®-T Easy Vector (Fig. 12C and 12D).    
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Electroporation was done as previously described into B. burgdorferi B31A.  Genotyping 
of the fliZ mutants was done with fliZ-P1F and fliZ-KOR.  
 
2.7 Complementation of fliZ in trans 
In order to complement the fliZ mutant in trans, the target gene was fused to its native 
flgB promoter (PflgB) using overlapping PCR (Figure 13).  PflgB was amplified from genomic 
DNA with primers GTCGACCCCGAGCTTCAAGGAAG (PflgB-F) and 
A 
C 
B 
D 
Figure 12. Schematic representation of the construction of ΔfliZ vehicle.  A) Step 1:  
Amplify DNA fragments with paired primers.  B) Join the first two fragments using 
overlapping PCR.  C) Connect the third fragment to the first two using overlapping PCR 
for the completed product (D).  
Wild type 
genome 
fliP 
fliP 
fliP 
fliP 
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TATTCATGAAACCTCCCTCATTTAAAATTGC (PflgB-R).   Primers 
GAGGTTTCATGAATAATAAATTTTTATTTTTAGTTT (fliZ-F) and 
GGATCCCTAAAATTTTTTTAATCTATCTTG (fliZ-R) were used to amplify fliZ from 
genomic DNA.  These two DNA fragments was amplified by overlapping PCR which creates a 
SalI site at the 5’- and a BamHI site immediately downstream of fliZ.  The construct was then 
inserted into pGEM®-T Easy Vector. The resulting plasmid was then restriction digested with 
BamHI and SalI, as was the pBSV2G shuttle vector.  Ligation of the two restriction digested 
fragments resulted in pBSV2G-fliZ
+
.  
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 The pBSV2G-fliZ
+ 
plasmid was electroporated in the B. burgdorferi B31A ΔfliZ strain 
and plated in to 96-well-plates with gentamicin and kanamycin.  Resistant clones were 
genotyped using PfligB-F and fliZ-R.   
A 
B 
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Figure 13. Schematic representation of the construction of ΔfliZ complementation vehicle.  
A) Step 1:  Amplify DNA fragments with paired primers.  B) Step 2:  Join the first two 
fragments using overlapping PCR to get (C).  D) Step 3: Ligate overlapping product into 
pGEM®-T Easy Vector. E) Digest the PCR product out with BamH1 and Sal1.  F) Ligate 
into pBSV2G for finished product.  
 
Wild type genome 
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2.8 Plasmid rescue assay for fliZ complement 
In addition to genotyping, the presence of pBSV2G-fliZ
+
 plasmid in the complemented 
fliZ (fliZ
+
) cells were confirmed by plasmid rescue as follows.  fliZ
+
 complement cells were 
grown in BSK-II media supplemented with 40 µg/ml gentamicin plus 200 µg/ml kanamycin.  As 
the cells reached mid-log phase, two ml of the cells were aliquoted into an Eppendorf tube, and 
the cells were spun down and washed with phosphate buffer saline (PBS) thrice.  DNA was then 
isolated and purified from the B. burgdorferi cells using the plasmid Miniprep kit as above.  10 
µL of this DNA was then transformed into E. coli strain JM109 and selected with 10 µg/ml of 
gentamicin.  Plasmid DNA was isolated from the gentamicin resistant colonies.  PCR was used 
to confirm the presence of the pBSV2G-fliZ
+
 plasmid. 
2.9 Inactivation of bb0773 
The bb0773 (425 bp) gene was inactivated using overlapping PCR as described for fliZ 
inactivation.  Parts one, two, and three contain overlapping sequences.  The final PCR product 
containing all three parts was ligated into pGEM®-T Easy Vector creating the Δbb0773-Easy 
plasmid (Figure 14).  Electroporation and platings were performed as described above into B. 
burgdorferi strain B31A. Genotyping of Δbb0773 was done using a primer that binds to the wild 
type, bb0773-P1F, and one that binds to the kanamycin cassette. 
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2.10 Western blotting 
 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and Western 
blotting with an enhanced chemiluminescent detection method were carried out according to the 
manufacturer's instructions (GE Healthcare).  A Bio-Rad Bradford assay was used to determine 
the relative concentration of proteins in the wild type and mutant cell lysates.  Equal portions of 
Figure 14. Schematic representation of the construction of Δbb0773 vehicle.  A) Step 1:  
Amplify DNA fragments with paired primers.  B) Join the first two fragments using 
overlapping PCR.  C) Connect the third fragment to the first two using overlapping PCR for 
the completed product (D).  
 
A 
B 
C 
D 
 
 
 
38 
 
the lysates was loaded in each lane for SDS-PAGE, transferred to polyvinylidene fluoride 
membranes, and subjected to Western blotting using specific antibodies.  Specific reactivities of 
the antibodies with B. burgdorferi proteins have been reported (74). 
 
2.11 Microscopy and computer-assisted motion analysis 
B. burgdorferi cells were observed using dark-field microscopy (Zeiss Axio Imager M1; 
Carl Zeiss Inc.) connected to an AxioCam digital camera to capture images.  Cells were 
suspended in BSK-II buffer containing 1% 400 mesh methylcellulose (Sigma-Aldrich Co.) and 
recorded at room temperature.  Cells were tracked using Axiovision software.  For each strain, at 
least 15 individual cells were recorded for up to 30 seconds.  Results are expressed as the total 
distance the center of each cell traveled/number of seconds the cell was tracked.  The resulting 
velocity (μm/s) is a minimal velocity, as cells do not translate during flexes.  The standard 
deviation of the results was calculated and compared using the Student’s t-test.  A P = 0.05 value 
is considered significant. 
2.12 Cryo-electron tomography 
Late log phase B. burgdorferi cells in a concentration of approximately 1 × 10
8
/ml  were 
centrifuged at 5,000 × g for 5 min in 1.5 ml tubes and the resulting pellet was rinsed gently with 
phosphate-buffed saline (PBS) prior to resuspension in 50 to 100 μl PBS for a final concentration 
of approximately 2 × 10
9
 cells/ml (79). Aliquots of micron gold clusters were added to the 
resuspended viable B. burgdorferi cells in PBS as reference markers for image alignment (86).   
4 µL of the cell samples were embedded in freshly glow-discharged holey carbon grids, flash 
frozen in liquid ethane and maintained at −180°C, using a homemade gravity-driven plunger 
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apparatus (79).  The frozen samples were imaged at the temperature of  liquid-nitrogen using a 
Polara electron microscope (FEI Company) equipped with a 4K × 4K charge-coupled-device 
camera (TVIPS; GMBH, Gauting, Germany) (79).  Low-dose single-axis-tilt (with tilt angles of 
± 65°)  series were collected from each cell at −4  to −6 μm defocus with a cumulative dose of  
approximately 100 e−/Å2 spread over 131 images using the FEI “batch tomography” software 
program.  .  Using reference markers and the IMOD software package, consecutively tilted 
images were aligned with respect to each other (79, 86) .  3-D cryo-tomograms were 
reconstructed using weighted back-projection implemented in the software package Protomo 
after additional refinement using projection matching (46).  
For 3-D classification and averaging, the positions and orientations of the flagellar 
motors in each tomogram were determined manually (79).  A point was marked at each: the 
center of the basal body, the turning point of the hook, and a point on the flagellar filament for 
each flagella image (79). This provided the x, y, and z coordinates to determine the orientation of 
the flagellar motor and was used for an initial estimate of the alignment parameters, which were 
afterward refined iteratively (79).  
A structure with 16-fold symmetry emerged after multiple cycles of alignment and 
averaging (79). To confirm this result, which was obtained by the alignment to a single 
reference, several cycles of a reference-free alignment procedure were applied (87).  A single 
cycle of the procedure consisted of a classification step, in which the data set was separated into 
20 classes (79). The class averages were then aligned with respect to each other and the 
alignment transformations of each class applied to the raw subvolumes of the respective 
members of the class, after which a new cycle was started (79).  
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Tomographic reconstructions were visualized by using IMOD (86).  The 3-D 
segmentations of flagellar filaments, peptidoglycan, outer surface proteins, and outer and 
cytoplasmic membranes were manually constructed (74).   
 
 
 
CHAPTER 3: RESULTS 
3.1 ∆cheY2 mutant and effects of chemotaxis on virulence.  
∆cheY1 and ∆cheY2 mutants were previously constructed in the high passage, avirulent strain, so 
their infection potential could not be evaluated.  To perform a mouse and tick-mouse infection 
assays, we needed to make mutants in B31A3 strain that retains all virulence associated 
plasmids. As such, we constructed a plasmid to inactivate the genes by inserting an antibiotic 
resistance cassette within cheY1 and cheY2 separately.  Since cheY2 is located at the end of its 
operon, a polar effect on downstream genes expression is not expected.  Accordingly, we 
inserted a PflgB-aph1 cassette within cheY2 (81).  This construct yielded cheY2 mutants in the 
virulent strain of B. burgdorferi as confirmed by genotyping and a Western blot using CheY2 
specific polyclonal antisera (Figure 15 and 16).  A similar construct in cheY1 has not yet yielded 
any mutants.
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        Wild type 
 
        ∆cheY2 
 
 
 
 
 
 
 
 
 
  
A 
1.5kb 
Figure 15. Genotyping of cheY2 mutant.  A)  Diagram showing the location of the 
primer sites arrows used for genotyping.  One primer binds to the PflgB-aphI cassette 
and the other to the cheY2 genomic DNA.  Resulting PCR is expected to yield a 1574 
bp band for the mutant and the positive control but no DNA band for wild type. B) 
Agarose gel displaying PCR results from cheY2 mutants.  Lanes 1 through 6 are 
mutants; lane 7 is the positive control, which is the ΔcheY2-Easy plasmid we used to 
construct the mutant.  Lane 8 shows wild type B. burgdorferi genomic DNA which was 
used as a negative control.  The DNA size marker is posted to the right. 
B 
 
1kb 
2kb 
wt + 1 2 3 4 5 
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Figure 16. Western blot of cheY2 mutant.  Equal amount of wild type and the mutant B. 
burgdorferi cell lysates was loaded in each lane for SDS-PAGE, transferred to 
polyvinylidene fluoride membranes, and subjected to Western blotting using anti B. 
burgdorferi CheY2 antibodies.  A protein band (12 kD) was detected in the wild type 
but not in the mutant.  As reported previously, this 12 kD band is CheY2. 
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3.2 Identification and characterization of a potential collar protein. 
To find the genes encoding the collar structure, we first wanted to identify possible 
candidates.  Rajagopala et al. provided a list of 176 motility protein interactions in Treponema 
pallidum that they created from known interactions from literature and from their own 
comprehensive array-based yeast-two-hybrid screens against Campylobacter jejuni (88).  
Additionally, more interactions were predicted based on interactions between other bacteria, 
such as E. coli, B. subtilis, C. jejuni, and Helicobacter pylori.  These data was processed with the 
STRING database to further refine the list of possible interactions.  In total, this involved 133 
proteins in T. pallidum, many of which have unknown functions (88).  The gene encoding the 
collar structure has not been identified in T. pallidum either, and since it also a spirochete, the list 
of unidentified motility genes is quite useful.  From this list, we wanted to determine if we could 
find homologues in B. burgdorferi.  We hypothesized that one of the proteins of unknown 
function could be a collar protein in T. pallidum.  To narrow down the list of possible candidates, 
we removed the homologues that have already been characterized in B. burgdorferi and other 
spirochetes because they cannot be the collar structure.  From the remaining genes, we further 
removed any genes that have homologues in non-spirochete species because the collar is unique 
to spirochetes. Additionally, based on cryo-ET data (Figure 16), the collar structure is located 
near the periplasmic flagellar motor (MotA and MotB), FliL, and situated on top of the MS-ring 
FliF proteins. This data served as a very good clue for us to look for any unidentified proteins 
that interacted with T. pallidum FliF, FliG, FliL, MotA or MotB.  One T. pallidum gene that we 
focused on was tp0708.  Rajagopala et al. indicated that this protein interacted with FlhA, FliG, 
FliF, and T. pallidum’s homologue of B. burgdorferi’s FlbB, a protein of unknown function in 
the flagellar (flgB) operon (89).  All of these genes function in motility, or are hypothesized to do 
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so.  FlhA, FliG-2, and FliF are known to localize close to the base of the basal body.  Also, 
Tp0708 has homologues only in spirochetes, which is important, because the collar structure is 
found only in spirochetes.  bb0526 is the B. burgdorferi locus that shares highest similarity with 
Tp0708.  These two proteins share an amino acid sequence identity of 28%.  bb0526 has not yet 
been characterized in any  spirochetes.  It appears to be the first gene in a bicistronic operon with 
bb0527.  Bb0527 is a putative baf family transcriptional activator.  There is no evidence that it 
plays any role in motility.  Similar to all known motility and chemotaxis genes in B. burgdorferi, 
bb0526 is located in the chromosome.  Additionally, as can be seen in the cryo-ET images, the 
collar structure is likely inserted to the (inner) membrane and thus this protein(s) could possess a 
transmembrane domain.  Based on these criteria, we predict that Bb0526 is a potential collar 
protein and may contribute to periplasmic flagellar assembly and motility.  
  Accordingly, we constructed mutants in B. burgdorferi avirulent and virulent 
backgrounds.  Genotyping of the mutants was done with PCR amplification and gel 
electrophoresis (Figure 17).  Our PCR results produced a 3.9 kb band for wild type and a 4.25 kb 
band for the mutant, as expected indicating we successfully isolated a bb0526 mutant (Figure 
17).  After creating these mutants, we determined if the mutant exhibits a phenotype.  We 
observed the cells under a dark-field microscope, noting a difference between the morphology of 
wild type cells and Δbb0526.  The Δbb0526 cells had a less pronounced wave-like morphology 
than the wild type (Figure 18).  To determine bb0526 mutant’s motility phenotype, we performed 
methylcellulose assays using dark-field microscopy and cell tracking software.  The 
methylcellulose assay revealed that the mutants had a significantly lower swimming velocity 
than the wild type cells (Figure 19). 
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Figure 17.  Genotyping of bb0526 mutants.  A) A diagram demonstrating the position of 
the primers.  Shown here are the results for B31A3 background.  Genotype results for 
B31A clones are not shown but are the same.  B) Agarose gel of PCR results of clones 1-
6.  The positive control (+) is the plasmid we used to create the mutant and the wild type 
(wt) is B. burgdorferi genomic DNA.  The expected size for the positive control and 
mutants is 3.90 kb and 4.25 kb for the wild type.  Based on this agarose gel, lanes 4 and 5 
are the expected bb0526 mutants. 
A 
B 
Wild type genome 
∆bb0526 genome 
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Figure 18.  Dark-field microscopy image of Δbb0526 cells.  A) Dark-field microscopy 
image of wild type cells.  B) Dark-field microscopy image of Δbb0526 cells indicating 
drastic reduction of flat-wave morphology. 
A B 
Δbb0526 
A 
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Additionally, when swimming, the mutant cells appeared slower and the movements of one pole 
of the cells was not coordinating with the other pole.     
 
 
 
 
3.3 bb0526 does not encode the collar structure, but may associate with it. 
Simultaneously, we analyzed the mutants with cryo-electron tomography to pinpoint the 
defect caused by the inactivation of bb0526.  The number of flagella did not differ from wild 
type (Table 1).  Examination of the mutant cells poles at a molecular level using cryo-ET 
revealed that the outer membrane, inner membrane, and peptidoglycan layers are intact.  The 
location of basal bodies and flagella are similar to wild type (Figure 20).  An image of the side 
view of the Δbb0526 flagellar basal body also reveals no differences from wild type (Figure 21).  
However, a close up view of the top of the basal bodies reveals that an area of lower density in 
the Δbb0526 basal body around the area of the stator.  The ruffling at the outer edge of the stator 
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Methylcellulose Assay Results 
For  ∆bb0526 
Figure 19.  Methylcellulose assay results.  This graph shows the results of three ∆bb0526 
methylcellulose trials in the B31A background.  The asterisks represent statistically 
significant difference from wild type based on the Students t-test (P = 0.05). 
* * * 
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appears to have less density in the Δbb0526 cells compared to the wild type, as can be seen in a 
computer aided model on Figure 21C,D,G,H.  Because of its location, our cryo-ET data suggests 
that BB0526 provides a connection between the stator and the collar. 
 
Cells Number of periplasmic 
flagella per cell: 
Sample Size: 
Wild Type 9.3±1.3 21 
Δbb0526 9.4±1.6  25 
 
 
 
 
 
 
Table 1.  Inactivation of Δbb0526 did not produce significantly less periplasmic flagella.  
This table shows the flagella count per cell of the ΔfliZ and the wild type cells with the 
standard deviations indicated by the “±”.  Statistically significant deviation from wild type 
is indicated by an asterisks where P = 0.05.  Data gathered by Jun Liu and Xiaowei Zhao 
from the University of Texas at Houston. 
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Figure 20. 3-D reconstruction of the cells of B. burgdorferi by cryo-electron tomography. 
(A) A Cryo-ET section (left panel) and surface rendering (right panel) from a wild type cell 
tomogram. (B) A Cryo-ET section (left panel) and surface rendering (right panel) from a 
∆bb0526 cell tomogram. OM: outer membrane; IM: inner membrane; PG: peptidoglycan.  
The OM (blue), IM (cyan), PG (white), and flagellar filament (yellow) were manually 
segmented by Amira.  Averaged structures of the flagellar motors were computationally 
mapped back into their cellular context.  Images created by Jun Liu and Xiaowei Zhao 
from the University of Texas at Houston. 
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C 
Figure 21. Averaged structures of the flagellar motors.  (A) Side view of wild type flagellar 
motor. The densities of the stators were outlined from the density map.  (B) Top view of the 
stators showing a ring-like structure composed of 16 particles.  (C, D) Surface-rendering of 
the wild type flagellar motor of B. burgdorferi.  (E-H) The flagellar motor of ∆bb0526.  The 
averaged structure shows the densities of stator are not as strong as those in wild type.  The 
differences in the flagellar motors of wild type and ∆bb0526 are highlighted in yellow.  
Images created by Jun Liu and Xiaowei Zhao from the University of Texas at Houston. 
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3.4 bb0773 is not required for wild type motility. 
Since bb0526 was found not to encode the main body of the collar structure, we 
identified bb0773 as a possible candidate.  B. burgdorferi’s bb0773 is a 435 base pair gene 
annotated as a hypothetical gene.  We selected bb0773 because of its location in the genome 
exclusively.  It is located in a cluster of several motility genes —bb0772 encodes the P-ring; 
bb774 encodes FlgG, the basal body rod protein, and bb0775 encodes the rod locates near the P-
ring (15).  All three proteins are located near the collar structure thus we hypothesized that a 
neighboring gene such as bb0773 likely encodes for the collar structure.  bb0773 appears to be 
monocistronic as it is separated from its neighboring genes on either side by more than 100 bp.  
To determine the role of Bb0773, we created mutants in this gene by overlapping PCR and 
genotyped it with PCR to confirm the mutation as shown in Figure 22 below.  The mutant cells 
and the positive control (Δbb0773-Easy) amplified a 2.1 kb product, while there was no band for 
the wild type as expected.  To determine if bb0773 mutant cells exhibit motility and morphology 
phenotypes we performed methylcellulose assays and dark-field microscopy, however, we have 
not detected any discernible defect in the mutant cells using these assays.  All results indicated 
that this mutant has wild type motility and morphology.  Cryo-ET imagery gave no indication of 
any defect either (data not shown).  Based on our data, we conclude that bb0773 has no 
observable phenotype with respect to motility, morphology, or motor structure using the 
conditions tested.  
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                        Wild type genome 
 
         ∆bb0773 genome 
                  
 
 
 
 
 
 
 
Figure 22.  Genotyping of bb0773 mutants.  A) A diagram demonstrating the 
position of the primers.  Shown here are the results for B31A background.  B) 
Agarose gel of PCR results of clones 1-5.  The positive control (+) is the plasmid we 
used to create the mutant and the wild type (wt) is B. burgdorferi genomic DNA.  
The expected size for the positive control and mutants is 2.1 kb and nothing is 
expected for the wild type. 
A 
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3.5 ∆fliZ cells have a reduced flagella count. 
In other bacteria such as S. enterica, inactivation of fliO, which is a fliZ homolog, 
resulted in mutant cells that are slower growing and less motile (83).  Recently we have reported 
that non-motile B. burgdorferi mutants are unable to establish infection in mice through needle 
injection or tick bite.  Additionally, the mutant spirochetes were unable to transmit from infected 
ticks to naive mice (19).  If B. burgdorferi’s fliZ is a true fliO homologue, we expect that the fliZ 
mutant cells will exhibit significantly decreased motility, this would allow us to test the 
hypothesis that B. burgdorferi requires full motility to be infective.  
 As mentioned before, we constructed a fliZ mutant plasmid using overlapping PCR to 
delete the fliZ by inserting a promoterless aphI.  Being in the middle of a long operon, the in-
frame insertion of a promoterless antibiotic resistance was reported to decrease the possibility of 
polar effects on downstream genes expression (90).  Through homologous recombination, we 
used this plasmid to inactivate fliZ in B. burgdorferi B31A, and then we genotyped the 
transformants using PCR (Figure 23).  Our PCR results produced a 1.72 kb band for the mutant 
and no band for the wild type, as expected indicating that we successfully isolated a fliZ mutant. 
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After inactivation and confirmation of the mutant, we examined the morphology of the 
ΔfliZ mutant using dark-field microscopy.  ΔfliZ cells displayed a similar morphology to the wild 
type, however the amplitude of the waves was noticeably decreased (Figure 24).   
  
Figure 23. Genotyping of fliZ mutants.  A) This diagram shows the primer binding sites 
(arrows).  One primer will only bind to the kanamycin resistance cassette, aphI, which 
is why there is no band in the wild type lane. B) Agarose gel displaying PCR product 
with the expected size of 1.72 kb from the B31A ∆fliZ mutants.  The lanes are labeled 
underneath the bands and the size of the DNA bands is posted to the right. The positive 
control in the last lane is the plasmid that we used to create the mutants.   
B 
A 
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 We also performed a methylcellulose assay to determine if the mutant had a motility 
phenotype.  Unlike the S. enterica fliO mutants, the B. burgdorferi fliZ mutants had no 
significant motility defects from wild type cells, despite the apparent difference in morphology 
(Figure 25).   
  
A B 
Figure 24. Dark-field microscopy of ΔfliZ cells.  A) This image shows wild type cells 
for comparison.  B) The ΔfliZ cells have a similar flat-wave morphology compared to 
the wild type cells; however, the amplitude of the waves is noticeably decreased in the 
ΔfliZ cells. 
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Simultaneously, we analyzed the mutants with cryo-electron tomography to determine 
the morphology caused by the absence of fliZ.  Cryo-ET revealed that the ΔfliZ mutants assemble 
flagella properly, in regards to the location and structures of the flagella and the flagella motors.  
However, the mutant cells synthesized and assembled less periplasmic flagella compared to wild 
type (Figure 26 and Table 2).   
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Motility Assay in Methylcellulose for 
ΔfliZ 
Figure 25.  Methylcellulose assay indicates that fliZ mutant cells are not less motile than 
the wild type cells.  This test was repeated three times (not shown) without a statistically 
significant difference from wild type based on the Students t-test (p=0.05). 
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Cells Number of periplasmic 
flagella per cell: 
Sample Size: 
Wild Type 9.3±1.3 21 
ΔfliZ (trial 1) 7.5±1.5 * 18 
ΔfliZ (trial 2) 6.5±1.8 17 
ΔfliZ complement (trial 2) 10.2±2.6 9 
 
 
 
 
  
Table 2.  Inactivation of fliZ produced significantly less periplasmic flagella than wild type.  
Our complement restored the wild type phenotype.  This table shows the flagella count per 
cell of the ΔfliZ and the wild type cells with the standard deviations indicated by the “±”.  
Statistically significant deviation from wild type is indicated by an asterisks where p= 0.05.  
Data gathered by Jun Liu and Xiaowei Zhao from the University of Texas at Houston. 
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  Figure 26.  Cryo-ET results of ∆fliZ cells.  A) This image shows the wild type flagella 
filament as it wraps around the cell cylinder. B) An image showing the ΔfliZ flagellar 
motors assembled at cell tip, where the flagella originate. C) Another image of the same 
cell showing the ΔfliZ flagellar filaments form a ribbon.  D) Image of wild type cell.  
The inset panel shows the cross-section of the wild type cell cylinder.  Filaments are 
stacked in the ribbon as indicated by the arrows.  E)  A section of the ∆fliZ core 
showing that the flagella are normally assembled in fliZ- cell. F) Image of ΔfliZ cell 
pole indicating proper location of flagella motors.  Images created by Jun Liu and 
Xiaowei Zhao from the University of Texas at Houston. 
ΔfliZ 
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To demonstrate that the fliZ mutant phenotype was due solely to the mutation and not due 
to a polar effects or a secondary alteration elsewhere, we complemented the mutant in trans 
using the pBSV2G-fliZ
+
 plasmid (figure 27). 
 
Figure 27.  Results of plasmid rescue for fliZ
+cells.  A) This diagram shows the 
primer binding sites (red arrows).  One primer binds fliZ and the other primer binds 
to PflgB, which is why there is no band in the wild type lane, for these fragments are 
too far apart from each other in the wild type genome. 
B) Agarose gel displaying PCR product with the expected size of 1040 bp for the 
fliZ
+
 cells.  The lanes are labeled underneath the bands and a DNA size marker is 
posted to the right.  The positive control in the middle lane is the plasmid that we 
used to create the mutant, pBSV2G-fliZ
+
. 
A 
B 
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The complemented cells were analyzed with cryo-ET to determine the restoration of the normal 
numbers of periplasmic flagella.  Our data indicate that the complemented fliZ
+
 cells had a 
restored flagella number compared to the wild type (Table 2).  Overall, our results indicate that 
unlike S. enterica, B. burgdorferi FliZ is crucial for controlling the flagellar number. 
 
 
CHAPTER 4: DISCUSSION 
4.1 cheY1 and cheY2 
The role of chemotaxis in establishing infection has been studied in many bacterial 
pathogens.  Helicobactor pylori, for example, requires chemotaxis to navigate to the mucosal 
membrane of the stomach wall (91).  Another bacterium, Campylobacter jejuni, has been shown 
to require chemotaxis in order to establish an infection (91).  Through the inactivation of cheA2, 
Sze et al. have shown B. burgdorferi also requires chemotaxis for establishment of infection 
(17).  One way to achieve a nonchemotactic mutant is to inactivate the cheY genes.  Inactivation 
of the cheY gene in E. coli leads to loss of chemotactic ability (58).  In B. burgdorferi, 
inactivation of cheY3 leads to nonchemotactic mutants (63).  Our unpublished results indicate 
that cheY3 mutant spirochetes are unable to establish infection in C3H/HeN mice.  Additionally, 
although ΔcheY3 cells are able to survive in ticks, those mutant cells are unable to transmit from 
the infected ticks to naïve mice.  Our results and data concur with Sze et al. and clearly 
demonstrate the importance of chemotaxis in vivo for B. burgdorferi.    
B. burgdorferi, however, has three copies of the cheY gene (15, 71)(71)(71).  Mutants in 
cheY1 and cheY2 have been shown to be chemotactic in vitro (63), thus their inactivation seemed 
to have no effect. We can say, however, that the growing B. burgdorferi cells actively transcribe 
and translate cheY1 and cheY2, so they are not pseudogenes (71).  We hypothesize that these 
genes are only necessary at certain phases of the spirochete’s lifecycle.  For example, one of the 
genes in question may be activated while B. burgdorferi is entering the tick and the other may be 
activated while exiting the tick or both genes are important for the tick-phase (acquisition and 
transmission or survivability in tick vector) of the spirochete’s enzootic cycle.  In order to 
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investigate the roles of CheY1 and CheY2 during the infectious life cycle of B. burgdorferi, we 
proposed to inactivate these genes in a virulent strain of B. burgdorferi.  So far, we have 
succeeded in making a cheY2 mutant in the virulent background that retained all endogenous 
plasmids required for virulence.  In contrast to our progress with cheY2, we have not been able to 
achieve any mutants in the virulent background with cheY1.  Genetic manipulations in B. 
burgdorferi are extremely difficult and it is not unusual to take multiple attempts in order to 
construct a mutant strain in the virulent background (19, 92).  While not completed, these 
mutants would make an excellent specimen for investigating the link between virulence and 
chemotaxis.  Preliminary data by Lin et al. indicates that cheY2 mutants are noninfectious in 
mice, demonstrating that while cheY2 may appear to be unnecessary for chemotaxis in vitro, it is 
required for survival in experimental mice (75).  Our cheY1 and cheY2 mutants would afford an 
opportunity to investigate further the function of chemotaxis in the future. 
4.2 bb0526 
The collar structure is one of the largest structures featured in cryo-ET images of B. 
burgdorferi’s periplasmic flagellar motors.  For this reason, we hypothesized that the collar 
structure plays a central role in the assembly or provide support to the flagella for efficient 
motility function.  We have determined that the B. burgdorferi bb0526 mutant has a swimming 
defect despite the possession of normal number of periplasmic flagella.  While it was not 
possible to discern the cause of the motility defect by dark-field microscopy we took advantage 
of cryo-ET that can detect individual flagellar structures at a molecular level.  We found that 
densities corresponding to a flagellar structure are missing near the base of the collar where the 
structure connects with the motor stator (MotA and MotB) suggesting that BB0526 corresponds 
to the base of the collar or is part of the collar structure.  The flagellum is a complex molecular 
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machine with each protein in a very precise place.  Our evidence indicates that BB0526 connects 
the collar structure to the stator and without this connection and support, the collar may be 
unable to provide the necessary support to the motors which resulted in decreased motility 
phenotype.  In order to confirm the hypothesis that BB0526 connects or binds the stator we plan 
to study protein-protein interactions between BB0526 and stator (MotA and MotB).  
  Our laboratory has reported that non-motile flaB mutants are unable to infect mice 
through needle injection or tick bites (19).  However, an incrementally reduced motility mutant 
has not been evaluated in the infectious life cycle of B. burgdorferi.  We posit that bb0526 
mutant is a good candidate for determining whether B. burgdorferi can still be infectious with 
limited motility.  We hypothesize that ∆bb0526 cells will be significantly less infectious than the 
wild type in mice.  If this turns out to be true, it will indicate that full motility is crucial for 
outsmarting host immune responses and establishment of infection.  Additionally, we 
hypothesize that the less motile bb0526 mutant will be unable or have limited ability to be 
acquired and/or transmitted by the tick in tick-mouse-tick cycle infections.  Previously we have 
reported that motility is important for B. burgdorferi’s intimate binding to the tick midguts and 
consequently, this binding provide survivability of the spirochetes in ticks (19).  Since bb0526 is 
not a non-motile mutant, we predict that bb0526 will be able to survive in fed ticks, but may not 
be able to transmit the infection to naïve mice.  We hypothesize that this defect will limit its 
ability to invade tissues within a host. 
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4.3 bb0773 
 Our results reveal no motility or chemotactic functions for bb0773.  There may, however, 
be other functions for this gene that are not related to motility or chemotaxis.  We will keep an 
open mind with this gene and explore its possibilities, should they arise in the future. 
4.4 fliZ 
In other bacteria inactivation of fliZ leads to slow growth and motility defects (83).  The 
aim of our research was to determine if inactivation of fliZ would create a similar slow mutant in 
B. burgdorferi, which would give us an opportunity to demonstrate the role of motility in 
infection.  After inactivating fliZ, we discovered a mutant with reduced number of periplasmic 
flagella, but we did not notice a motility defect.  However, this result could be due to a lack of 
sensitivity in our methods.  If a lack of sensitivity is not a problem, we assume that FliZ is a 
protein that is involved in regulating the number of periplasmic flagella.  The restoration of the 
wild type phenotype through complementation supports our hypothesis that fliZ was the cause of 
this reduction in flagella. 
FlhF and FlhG are known regulators of the flagella numbers in Vibrio spp. (V. cholera 
and V. alginolyticus) (93-95)  and C. jejuni (96), however, there is no evidence that fliZ 
associates with these well-known regulators.  B. burgdorferi possesses a homolog of FlhF and 
FlhG (15).  Although not known, it is possible that FliZ interacts with these proteins in order to 
control the number of periplasmic flagella or FliZ may act alone to control the flagellar number 
in the spirochetes.  Alternatively, we believe the cause of the reduced numbers of periplasmic 
flagella is a result of the lack of stability in FliP, a protein that FliZ regulates in other bacteria 
(83).  FliP is a known flagellar protein that is involved in exporting flagella using type-III 
secretion system (83). 
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We were surprised that we could not detect a motility defect, despite the reduced number 
of periplasmic flagella in the fliZ mutant cells using the bacterial tracking software.  We will 
perform swarm plate motility assays that require extended period of incubation for the cells to 
swarm out from the initial site of inoculation in the soft-agarose plate.  If, by swarm plate assay, 
we find that the fliZ mutant exhibits reduced motility due to possessing less periplasmic flagella, 
it will be intriguing to determine whether or not B. burgdorferi needs full motility to be 
infectious in its natural lifecycle.  While we are in a good position to determine if full motility is 
important for the infectious life cycle of B. burgdorferi using bb0526 and fliZ mutants, it is 
important to note that these two mutants are different.  While bb0526 exhibits a reduced motility 
phenotype due to inefficient interactions between the stator and collar, the fliZ mutant cells 
possess less periplasmic flagella.  We have laid the groundwork for such an experiment in the 
future. 
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